Clinical Trials Browser

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

Stomach Neoplasms

Biliary Tract Neoplasms

Gynecological Malignancy

Lymphoma, Large B-Cell, Diffuse

Solid Tumors

Advanced Malignant Tumor

Differentiated Thyroid Cancer

Recurrence, Lymphoma, Large B-Cell, Diffuse

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Advanced Solid Tumor

Advanced Solid Tumor

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Breast Neoplasms

Breast Neoplasms

Advanced Malignant Neoplasm

Prostatic Neoplasms

Advanced or Metastatic Solid Tumors

Esophageal Squamous Cell Carcinoma

Pancreatic Neoplasms

Advanced Breast Cancer

Gastric Adenocarcinoma

Advanced Solid Tumors

Locally Advanced/Metastatic Solid Tumours

Platinum-resistant Recurrent Ovarian Cancer

Malignant Solid Tumors

Advanced Malignant Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Nasopharyngeal Carcinoma

Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Advanced Lung Carcinoma

Leukemia, Myeloid, Acute

Carcinoma, Non-Small-Cell Lung

Triple Negative Breast Neoplasms

PD-L1 Positive Non-small Cell Lung Cancer

HER2-Positive Solid Tumors

HER2-positive Advanced Breast Cancer

Carcinoma, Hepatocellular

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Thoracic Neoplasms

Carcinoma, Non-Small-Cell Lung

Clinical Trials

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)

A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression

A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer

A Study of RC48-ADC for the Treatment of HER2-expressing Gynecological Malignancies

Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

A Study of RC98 in Subjects With Advanced Malignant Solid Tumors

Phase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant Tumors

A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors

DTC

Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects

Pediatric_PK

A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors

A Study of 7MW3711 in Subjects With Advanced Solid Tumors

Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy

FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.

Clinical Trial Evaluating the Safety of the TQB2103 for Injection

Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg

Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients

A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC)

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer

A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of Patients

Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT8009

A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian Cancer

A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors

A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Patients

A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid Tumors

The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and Taxotere

A Study of Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid Tumors

SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor

A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer

Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients

Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC

Phase I Clinical Study for Evaluation of Pharmacokinetic, Safety, Tolerance of Norcantharidin Lipid Microsphere for Injection in Patients With Solid Tumor

A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC)

Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer (NSCLC)

A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients

The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer

Expanding Phase III Study of Tyroserleutide for Injection

A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection

Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI